Fenoterol versus salbutamol nebulization in asthma

Area of Science:

• Pharmacology
• Respiratory Medicine
• Clinical Trials

Background:

• Asthma management relies on bronchodilators to relieve airway obstruction.
• Short-acting beta-agonists are commonly used for acute symptom relief.

Purpose of the Study:

• To compare the efficacy of fenoterol and salbutamol in stable asthmatics.
• To evaluate the peak effect and duration of action of both bronchodilators.

Main Methods:

• A double-blind, crossover study design.
• Involving 10 stable asthma patients.
• Administration of 5 mg fenoterol and 5 mg salbutamol via Hudson nebulizer.

Main Results:

• Both fenoterol and salbutamol produced significant bronchodilation.
• Fenoterol exhibited a significantly greater peak bronchodilator effect.
• Fenoterol's duration of action was 4 hours, compared to 3 hours for salbutamol.

Conclusions:

• Fenoterol offers a superior bronchodilator response in stable asthmatics compared to salbutamol.
• The longer duration of action of fenoterol may be clinically advantageous.
• Further research could explore optimal dosing and long-term effects.